Allergan and AstraZeneca Commit to Antibiotic Development Deal

According to Genengnews.com, “Dublin-based Allergan has entered into an agreement with AstraZeneca to develop and commercialize a fixed-dose antibiotic formulation currently in Phase II study. The financial terms of the agreement were not detailed, though...